(Q33562953)

English

Natural killer cell activity in Sjögren's syndrome and systemic lupus erythematosus: stimulation with interferons and interleukin-2 and correlation with immune complexes

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Natural killer cell activity in Sjögren's syndrome and systemic lupus erythematosus: stimulation with interferons and interleukin-2 and correlation with immune complexes (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

0 references

Sjögren's syndrome

1 reference

based on heuristic

inferred from title

systemic lupus erythematosus

1 reference

based on heuristic

inferred from title

author name string

Struyf NJ

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Snoeck HW

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Bridts CH

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

De Clerck LS

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Stevens WJ

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

language of work or name

0 references

publication date

1 September 1990

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

49

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

690-693

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004205

21 June 2018

Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004205

21 June 2018

Natural killer cell in systemic lupus erythematosus. Defects in effector lytic activity and response to interferon and interferon inducers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004205

21 June 2018

Natural killer cells and interferon responses in patients with systemic lupus erythematosus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004205

21 June 2018

Studies of the function of natural killer-interferon system in patients with Sjögren syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004205

21 June 2018

Partial purification and characterization of systemic lupus erythematosus derived factors that suppress production of interleukin-2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004205

21 June 2018

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004205

21 June 2018

Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004205

21 June 2018

Interleukin 2 augmentation of the defective natural killer cell activity in patients with primary Sjögren's syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004205

10 December 2018

Interleukin 2 receptors and responsiveness to recombinant human interleukin 2 in patients with systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/1700674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective impairment of alpha-interferon-mediated natural killer augmentation in Sjögren's syndrome: differential effects of alpha-interferon, gamma-interferon, and interleukin 2 on cytolytic activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/1700674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum levels of interferons in patients with systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/1700674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural killer cell activity in the systemic connective tissue diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/1700674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of IgM-rheumatoid factor interference in the determination of total serum IgE and IgE-containing circulating immune complexes

1 reference

https://pubmed.ncbi.nlm.nih.gov/1700674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A fluorescence NK assay using flow cytometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/1700674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating natural killer cells in Sjögren's syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/1700674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon and natural killer cells in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/1700674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon production of vitro by leucocytes from patients with systemic lupus erythematosus and rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/1700674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endogenous and interferon-augmented natural killer cell activity of human peripheral blood mononuclear cells in vitro. Studies of patients with multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/1700674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insensitivity to interferon of NK cells from patients with systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/1700674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/1700674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 2 dependence of human natural killer (NK) cell activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/1700674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired natural killer cell function in systemic lupus erythematosus. Relationship to interleukin-2 production

1 reference

https://pubmed.ncbi.nlm.nih.gov/1700674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural killer cells in systemic lupus erythematosus. Abnormal numbers and functional immaturity of HNK-1+ cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/1700674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural cytotoxicity in systemic lupus erythematosus: mechanisms of suppression by inhibitory serum factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/1700674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A method for rapid determination of IgG containing circulating immune complexes using polyethyleneglycol and radioactively labeled protein A

1 reference

https://pubmed.ncbi.nlm.nih.gov/1700674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural cytotoxicity in rheumatoid arthritis and systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/1700674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural cell mediated cytotoxicity in systemic lupus erythematosus: suppression by antilymphocyte antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/1700674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural cell-mediated cytotoxicity in Sjögren's syndrome and rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/1700674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired expression of high affinity interleukin 2 receptor on activated lymphocytes from patients with systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/1700674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/ARD.49.9.690

1 reference

https://api.fatcat.wiki/v0/release/ue7xsm3ftzh55ejck2x3eii3sm

30 July 2022

based on heuristic

mapped directly with Wikidata item

release_ue7xsm3ftzh55ejck2x3eii3sm

1 reference

https://api.fatcat.wiki/v0/release/ue7xsm3ftzh55ejck2x3eii3sm

30 July 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

https://api.fatcat.wiki/v0/release/ue7xsm3ftzh55ejck2x3eii3sm

30 July 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

https://api.fatcat.wiki/v0/release/ue7xsm3ftzh55ejck2x3eii3sm

30 July 2022

based on heuristic

mapped directly with Wikidata item

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33562953&oldid=1801534483"